Table 2.
Histologic findings as related to LN status.
| LN+ (n = 11) | LN– (n = 29) | |
|---|---|---|
| Histologic diagnosis | ||
| Tubulopapillary adenocarcinoma | 1/11 (9.10%) | 0/29 |
| Bronchoalveolar carcinoma | 4/11 (36.36%) | 21/29 (72.41%) |
| Papillary pulmonary carcinoma | 3/11 (27.27%) | 7/29 (24.14%) |
| Adenosquamous carcinoma | 2/11 (18.18%) | 1/29 (3.45%) |
| Anaplastic carcinoma | 1/11 (9.10%) | 0/11 |
| MI < 10 | 5/11 (45.45%) | 12/29 (41.38%) |
| MI > 10 | 8/11 (72.72%) | 13/29 (44.83%) |
| Vascular/lymphatic invasion | Yes 4/11 (36.36%) | Yes 5/29 (17.24%) No 17/29 (58.62%) |
| Intrabronchial seeding | 1/11 (9.10%) | 0 |
| Grade | ||
| I | 0 | 3/29 (10.34%) |
| II | 3/11 (27.27%) | 14/29 (58.62%) |
| III | 0 | 0 |
| “High” | 1/11 (9.10%) | 0 |
| Not reported | 7/11 (63.64%) | 12/29 (41.38%) |
| Margins | ||
| Complete | 4/11(36.36%) | 27/32 (93.10%) |
| Incomplete | 6/11 (54.55%) | 0 |
| Not reported | 1/11 (9.10%) | 2/29 (6.90%) |